Barr Labs to buy back up to $100 mln shares MONDAY, SEPTEMBER 17, 2001 9:18 AM - Reuters POMONA, N.Y., Sept 17 (Reuters) - Generic drugmaker Barr Laboratories, Inc. (NYSE:BRL) said Monday its board of directors authorized management to allocate up to $100 million to repurchase shares of the company`s common stock. It said this authorization represents management`s confidence in the stock market and the economy, and its confidence in the prospects for the company. Barr said the board authorized management to act at its discretion to ensure stability of the trading of Barr`s common shares. Barr stock closed on the New York Stock Exchange at $81.20 on Sept 10 |
|
aus der Diskussion: | generics |
Autor (Datum des Eintrages): | dosto (20.09.01 11:08:06) |
Beitrag: | 16 von 125 (ID:4460524) |
Alle Angaben ohne Gewähr © wallstreetONLINE |